Projects per year
Personal profile
Research Strategic Pillar
Dr. Randall Urban, VP and Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Brain Health
- Life Span Health
- Infectious/ Immunological Health
- Specialized Health
- Metabolic Health
Fingerprint
Dive into the research topics where Xuping Xie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
SAVE Variant Pipeline-SARS-CoV-2 variants serum neutralization analysis
Xie, X. (PI)
American Type Culture Collection
9/26/23 → 9/25/28
Project: Research project
-
Inhibitory activities of compounds against flaviviruses
Xie, X. (PI)
3/2/23 → 12/31/24
Project: Research project
-
Perform testing in support of PFIZER pre-clinical anti-SARS-CoV-2 mAb program as directed by PFIZER
Xie, X. (PI)
12/7/22 → 3/7/25
Project: Research project
-
Involving the testing of compounds against SARS-CoV-2
Xie, X. (PI)
10/25/22 → 12/31/24
Project: Research project
-
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery
Bolinger, A. A., Li, J., Xie, X., Li, H. & Zhou, J., 2024, In: Expert Opinion on Drug Discovery. 19, 9, p. 1023-1041 19 p.Research output: Contribution to journal › Article › peer-review
-
Metformin restrains ZIKV replication and alleviates virus-induced inflammatory responses in microglia
Wang, X., Wang, H., Yi, P., Baker, C., Casey, G., Xie, X., Luo, H., Cai, J., Fan, X., Soong, L., Hu, H., Shi, P. Y., Liang, Y. & Sun, J., Aug 2023, In: International Immunopharmacology. 121, 110512.Research output: Contribution to journal › Article › peer-review
-
Corrigendum to “Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics” “Antiviral Research 209 (2023)/105484” (Antiviral Research (2023) 209, (S0166354222002534), (10.1016/j.antiviral.2022.105484))
Perez-Vargas, J., Shapira, T., Olmstead, A. D., Villanueva, I., Thompson, C. A. H., Ennis, S., Gao, G., De Guzman, J., Williams, D. E., Wang, M., Chin, A., Bautista-Sanchez, D., Agafitei, O., Levett, P., Xie, X., Nuzzo, G., Freire, V. F., Quintana-Bulla, J. I., Bernardi, D. I. & Gubiani, J. R. & 25 others, , May 2023, In: Antiviral research. 213, 105577.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-2
Bills, C., Xie, X. & Shi, P.-Y., May 2023, In: Antiviral research. 213, 105590.Research output: Contribution to journal › Review article › peer-review
Open Access -
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
C4591007 Clinical Trial Group, Apr 1 2023, In: Journal of the Pediatric Infectious Diseases Society. 12, 4, p. 234-238 5 p.Research output: Contribution to journal › Article › peer-review
Open Access